Progress in Hematopoietic Stem Cell Transplantation and Cellular Therapies

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00669806%3A_____%2F22%3A10452406" target="_blank" >RIV/00669806:_____/22:10452406 - isvavai.cz</a>
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=TZ673EW5xU" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=TZ673EW5xU</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3390/jcm11247354" target="_blank" >10.3390/jcm11247354</a>

Result language
angličtina
Original language name
Progress in Hematopoietic Stem Cell Transplantation and Cellular Therapies
Original language description
Hematological malignancies are considered to be one of the most important causes of mortality and morbidity in the modern world. Still, important progress has been made in the last decade due to breakthroughs in hematopoietic stem cell transplantation and cellular therapies. The results of these recent studies show that a promising road toward state-of-the-art treatment for the hematology patient, turning the diagnosis of leukemia or lymphoma into a curable disease, has already begun, with recent advances in hematopoietic stem cell transplantation and immunotherapy, and is now progressing forward. The prospect of providing a definitive alternative therapy for various malignancies, rather than conventional chemotherapy management, is indeed clinically, socially, and economically attractive, due to the huge medical, social, and economic burden that a malignancy imposes.
Czech name
—
Czech description
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)